{"brief_title": "Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)", "brief_summary": "Serious infections caused by resistant bacteria are becoming more of a medical problem throughout the world. This study will measure how well TD-6424 (Telavancin) can control infections and whether the drug is safe to give to patients.", "condition": ["Infections, Gram-Positive Bacterial"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["Telavancin", "vancomycin or antistaphylococcal penicillin"], "description": ["Telavancin 7.5 mg/kg/day, amended to 10 mg/kg/day, IV (intravenously) for up to 14 days", "Vancomycin 1 Gram IV (intravenously) every 12 hrs or nafcillin 2 Grams, oxacillin 2 Grams, or (in South Africa) cloxacillin 0.5 - 1 Gram, IV (intravenously) every 6 hrs for up to 14 days."], "arm_group_label": ["Telavancin", "Standard of care for cSSSI"], "other_name": ["TD-6424", "VIBATIV"], "criteria": "Inclusion Criteria: - Patients must have a diagnosis of one of the following complicated skin and soft tissue infections and either a suspected or confirmed Gram positive organism - major abscess requiring surgical incision and drainage - infected burn (see exclusion criteria for important qualifications) - deep/extensive cellulitis - infected ulcer (see exclusion criteria for important qualifications) - wound infection - Patients must be expected to require at least 4 days of intravenous (IV) antibiotic treatment Exclusion Criteria: - Previous systemic antibacterial therapy (with the exception of aztreonam and metronidazole) for > 24 hours within 7 days prior to the first dose of study drug unless the pathogen was resistant to prior treatment or the patient was a treatment failure (no clinical improvement after 3 days) - Burns involving > 20% of body surface area or third degree/full thickness in nature, diabetic foot ulcers, ischemic ulcers/wounds, necrotizing fasciitis, gas gangrene, or mediastinitis", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Wound infections", "mesh_term": ["Infection", "Communicable Diseases", "Gram-Positive Bacterial Infections", "Penicillins", "Vancomycin", "Telavancin"], "id": "NCT00077675"}